Immediate Impact
58 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
Works of Andrew M. Frederickson being referenced
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andrew M. Frederickson | 434 | 454 | 114 | 40 | 655 | |
| Xiaojun You | 226 | 627 | 212 | 50 | 815 | |
| Luis J. Mejico | 310 | 90 | 49 | 29 | 592 | |
| John E. Mignano | 138 | 168 | 109 | 38 | 641 | |
| P Vandermarcq | 447 | 339 | 36 | 42 | 686 | |
| Angeliki Filippatou | 275 | 347 | 17 | 34 | 746 | |
| Ryosuke Okumura | 158 | 111 | 69 | 31 | 592 | |
| Karthinathan Thangavelu | 224 | 575 | 237 | 58 | 764 | |
| Thierry Lefrancq | 204 | 274 | 68 | 31 | 602 | |
| Lawrence H. A. Gold | 279 | 101 | 29 | 36 | 612 | |
| Yukari Takase | 300 | 73 | 89 | 39 | 831 |
All Works
Login with ORCID to disown or claim papers
Loading papers...